Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Goldberg

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Iscience|February 16, 2019
CRISPR-Mediated Editing of the B Cell Receptor in Primary Human B CellsVera Greiner, Regina Bou Puerto, Suying Liu, et al.
Biomacromolecules|September 25, 2014
Dual-layer surface coating of PLGA-based nanoparticles provides slow-release drug delivery to achieve metronomic therapy in a paclitaxel-resistant murine ovarian cancer modelZohreh Amoozgar, Lei Wang, Tania Brandstoetter, et al.
Cancer Immunology Research|June 10, 2015
Decitabine Enhances Lymphocyte Migration and Function and Synergizes with CTLA-4 Blockade in a Murine Ovarian Cancer ModelLei Wang, Zohreh Amoozgar, Jing Huang, et al.
Science Translational Medicine|March 23, 2018
Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastasesChun Gwon Park, Christina A Hartl, Daniela Schmid, et al.
Science Translational Medicine|January 3, 2014
Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in miceAmy Brock, Silva Krause, Hu Li, et al.
Biochemical and Biophysical Research Communications|June 7, 2015
The PARP1 inhibitor BMN 673 exhibits immunoregulatory effects in a Brca1(-/-) murine model of ovarian cancerJing Huang, Lei Wang, Zhongyi Cong, et al.
Journal for Immunotherapy of Cancer|August 1, 2019
Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancerChristina A Hartl, Adrian Bertschi, Regina Bou Puerto, et al.
Nano Letters|March 22, 2012
Remotely activated protein-producing nanoparticlesAvi Schroeder, Michael S Goldberg, Christian Kastrup, et al.
The Journal of Investigative Dermatology|August 13, 2013
Transcription factor/microRNA axis blocks melanoma invasion program by miR-211 targeting NUAK1Rachel E Bell, Mehdi Khaled, Dvir Netanely, et al.
Nature Communications|November 25, 2017
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunityDaniela Schmid, Chun Gwon Park, Christina A Hartl, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Iscience|February 16, 2019
CRISPR-Mediated Editing of the B Cell Receptor in Primary Human B CellsVera Greiner, Regina Bou Puerto, Suying Liu, et al.
Biomacromolecules|September 25, 2014
Dual-layer surface coating of PLGA-based nanoparticles provides slow-release drug delivery to achieve metronomic therapy in a paclitaxel-resistant murine ovarian cancer modelZohreh Amoozgar, Lei Wang, Tania Brandstoetter, et al.
Cancer Immunology Research|June 10, 2015
Decitabine Enhances Lymphocyte Migration and Function and Synergizes with CTLA-4 Blockade in a Murine Ovarian Cancer ModelLei Wang, Zohreh Amoozgar, Jing Huang, et al.
Science Translational Medicine|March 23, 2018
Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastasesChun Gwon Park, Christina A Hartl, Daniela Schmid, et al.
Science Translational Medicine|January 3, 2014
Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in miceAmy Brock, Silva Krause, Hu Li, et al.
Biochemical and Biophysical Research Communications|June 7, 2015
The PARP1 inhibitor BMN 673 exhibits immunoregulatory effects in a Brca1(-/-) murine model of ovarian cancerJing Huang, Lei Wang, Zhongyi Cong, et al.
Journal for Immunotherapy of Cancer|August 1, 2019
Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancerChristina A Hartl, Adrian Bertschi, Regina Bou Puerto, et al.
Nano Letters|March 22, 2012
Remotely activated protein-producing nanoparticlesAvi Schroeder, Michael S Goldberg, Christian Kastrup, et al.
The Journal of Investigative Dermatology|August 13, 2013
Transcription factor/microRNA axis blocks melanoma invasion program by miR-211 targeting NUAK1Rachel E Bell, Mehdi Khaled, Dvir Netanely, et al.
Nature Communications|November 25, 2017
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunityDaniela Schmid, Chun Gwon Park, Christina A Hartl, et al.
Pageof 3